MENU
GOSS
AS OF
Dec 24 closing price
Price
$3.44
Change
+$0.15 (+4.56%)
Capitalization
796.21M
78 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
GOSS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Gossamer Bio (GOSS) Ownership - Who owns Gossamer Bio?

Gossamer Bio Inc is a clinical-stage biopharmaceutical company... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
3013 Science Park Road
Phone
+1 858 684-1300
Employees
135
Web
https://www.gossamerbio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
796.21M
P/E Ratio
N/A
Total Cash
180.22M
Projected Growth
N/A
Total Debt
202.88M
Revenue
44.05M
Risk (Beta)
4.21
Dividend Yield
N/A
Total Cash/Share
0.78
Total Debt/Equity
N/A
Revenue/Share
0.19 USD as % of share price

Fundamentals

GOSS
Capitalization
796M
P/E Ratio
N/A
Risk (Beta)
4.21
Dividend Yield
N/A
Total Cash
180M
Total Cash/Share
0.78
Total Debt
203M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.19%
Revenue
44.1M
ROE
N/A
Book Value
-82.33M
P/B Ratio
8.09
Cash Flow
N/A
Earnings
-0.69
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
24K
Current Ratio
3.28
Current Revenue Per Employee
91682.76
Dividends Per Share - Security
N/A
EBITDA
-145.74M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-55.80
Shares Held By Institutions
586M
Shares Outstanding - Current
231M
Total Liabilities
291M
Total Volume MTD
N/A
Value
N/A
Gain YTD
280.279
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
GOSS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GOSS showed earnings on November 05, 2025. You can read more about the earnings report here.
View AI-Driven Trading for GOSS
A.I. Advisor
published General Information

General Information

a company, which engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
3013 Science Park Road
Phone
+1 858 684-1300
Employees
135
Web
https://www.gossamerbio.com